S-588210

N/A

Report date: 2022/12/31 17:30:14

Base Information

Drug NameS-588210
Drug Alias NameMultipeptide vaccine(Shionogi)S-588210S-488210/S-488211
ClassificationVaccines > Development/production technology > Synthetic peptide vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsUrinary Bladder NeoplasmsLung NeoplasmsHead and Neck Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesOncotherapy Science, Inc
China Registration ClassN/A

Develop Information

Active CompaniesUniversity College LondonShionogi & Co Ltd
Inactive CompaniesThe University Of Chicago
Active IndicationsUrinary Bladder NeoplasmsLung NeoplasmsHead and Neck Neoplasms +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A